Matches in Ubergraph for { <http://purl.obolibrary.org/obo/NCIT_C161925> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- NCIT_C161925 IAO_0000115 "A chemotherapy regimen consisting of cytarabine (Ara-C), topotecan, and gemtuzumab ozogamicin that may be used as induction therapy in myelodysplastic syndrome (MDS) and for the treatment of secondary or relapsed acute myeloid leukemia (AML)." @default.
- NCIT_C161925 NCIT_NHC0 "C161925" @default.
- NCIT_C161925 NCIT_P106 "Therapeutic or Preventive Procedure" @default.
- NCIT_C161925 NCIT_P108 "ATGO Regimen" @default.
- NCIT_C161925 NCIT_P208 "CL970534" @default.
- NCIT_C161925 NCIT_P322 "SEER" @default.
- NCIT_C161925 NCIT_R123 NCIT_C129821 @default.
- NCIT_C161925 NCIT_R123 NCIT_C129823 @default.
- NCIT_C161925 NCIT_R123 NCIT_C129824 @default.
- NCIT_C161925 NCIT_R123 NCIT_C129825 @default.
- NCIT_C161925 NCIT_R123 NCIT_C1512 @default.
- NCIT_C161925 NCIT_R123 NCIT_C1557 @default.
- NCIT_C161925 NCIT_R123 NCIT_C1748 @default.
- NCIT_C161925 NCIT_R123 NCIT_C1806 @default.
- NCIT_C161925 NCIT_R123 NCIT_C186664 @default.
- NCIT_C161925 NCIT_R123 NCIT_C1904 @default.
- NCIT_C161925 NCIT_R123 NCIT_C1908 @default.
- NCIT_C161925 NCIT_R123 NCIT_C1909 @default.
- NCIT_C161925 NCIT_R123 NCIT_C2189 @default.
- NCIT_C161925 NCIT_R123 NCIT_C2333 @default.
- NCIT_C161925 NCIT_R123 NCIT_C272 @default.
- NCIT_C161925 NCIT_R123 NCIT_C274 @default.
- NCIT_C161925 NCIT_R123 NCIT_C2828 @default.
- NCIT_C161925 NCIT_R123 NCIT_C2843 @default.
- NCIT_C161925 NCIT_R123 NCIT_C307 @default.
- NCIT_C161925 NCIT_R123 NCIT_C308 @default.
- NCIT_C161925 NCIT_R123 NCIT_C408 @default.
- NCIT_C161925 NCIT_R123 NCIT_C471 @default.
- NCIT_C161925 normalizedInformationContent "100" @default.
- NCIT_C161925 referenceCount "1" @default.
- NCIT_C161925 hasExactSynonym "ATGO Regimen" @default.
- NCIT_C161925 hasExactSynonym "ATGO" @default.
- NCIT_C161925 hasExactSynonym "Ara-C/Topotecan/Gemtuzumab Ozogamicin" @default.
- NCIT_C161925 hasExactSynonym "Cytarabine-Topotecan-Gemtuzumab Ozogamicin Regimen" @default.
- NCIT_C161925 hasExactSynonym "Cytarabine-Topotecan-Gemtuzumab Ozogamicin" @default.
- NCIT_C161925 hasExactSynonym "Cytarabine/Gemtuzumab Ozogamicin/Topotecan" @default.
- NCIT_C161925 inSubset NCIT_C160952 @default.
- NCIT_C161925 inSubset NCIT_C167078 @default.
- NCIT_C161925 inSubset NCIT_C167080 @default.
- NCIT_C161925 type Class @default.
- NCIT_C161925 isDefinedBy ncit.owl @default.
- NCIT_C161925 label "ATGO Regimen" @default.
- NCIT_C161925 subClassOf B03ad642578777c485c205c4566e985e9 @default.
- NCIT_C161925 subClassOf B29bd40fe8922a1bc9f0abde0cced0290 @default.
- NCIT_C161925 subClassOf B331b437ceae4d598ab4d88b03a6573d1 @default.
- NCIT_C161925 subClassOf B3879600554e6e51a9a7aaea5319fe548 @default.
- NCIT_C161925 subClassOf B9c559ee3d12a72b8eabc3b4fcd9ef06e @default.
- NCIT_C161925 subClassOf Ba3d002b3820b263e94fee5a4aac553c3 @default.
- NCIT_C161925 subClassOf NCIT_C12218 @default.
- NCIT_C161925 subClassOf NCIT_C159872 @default.
- NCIT_C161925 subClassOf NCIT_C161925 @default.
- NCIT_C161925 subClassOf NCIT_C173974 @default.
- NCIT_C161925 subClassOf NCIT_C186720 @default.
- NCIT_C161925 subClassOf NCIT_C186724 @default.
- NCIT_C161925 subClassOf NCIT_C62634 @default.
- NCIT_C161925 subClassOf NCIT_C63589 @default.